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INTRODUCTION
The amnestic subtype of MCI (Mild cognitive impairment) is usually caused by a degenerative etiology, and most frequently represents a prodromal stage of AD (Alzheimer's disease). Form an epidemiologic perspective, the rates of progression to AD range from 6 to 10% per year but in the referral clinical setting the rates are higher (10-15% per year) [1] . The definitive diagnosis of AD can only be based on the combination of symptoms plus histopathology, with the presence of large number of neuritic plaques and neurofibrillary tangles in brain tissues [2] . The search for noninvasive diagnostic methods has been of considerable interest, because, apart from allowing detection of those who develop AD, they will serve to monitor changes and assess the effects of drugs in AD [3] .
Atrophy of the hippocampus, and entorhinal cortex as well, are frequent prodromal signs of AD in subjects with MCI [4] [5] [6] [7] [8] . Whole brain, cortical, and ventricular volumes have also shown to be associated with progression to AD, although the volume measurements from MR images have relatively low accuracy in the prediction of AD [9] [10] [11] [12] .
Proton magnetic resonance spectroscopy (1H-MRS) is one of the techniques used to assess potential disruptions of neuronal integrity and associated neurochemical dysregulations. MRS provides additional biochemical information, which can be useful to determine the clinical stratification for a specific patient. Myo-Inositol (mI) is considered a glial marker, and as a possible degradation product of myelin and osmolyte or regulator of cell volume. Choline (Cho) is a constituent of phospholipids metabolism of cell membranes and reflects cell proliferation. Creatine (Cr) plays an important role in brain energy system (ATP), a marker of brain metabolism. The Nacetylaspartate (NAA) is a marker of neuronal and axonal density and mitochondrial functioning. Glutamate (Glu) is the primary excitatory neurotransmitter in the brain. Studies have shown that the ratio of Nacetylaspartate/creatine can predict with high accuracy conversion from MCI to AD [13] [14] [15] . Also increased mI/Cr and decreased NAA/Cr ratios correlated
well with the severity of AD [16] . Hitherto studies suggest that MRS combined with measurements of brain volumes can provide neuroimaging markers of disease progression .
The purpose of this study is to explore whether the changes in brain volumes and metabolite levels are associated with cognitive decline and the development of dementia in amnestic-MCI patients over time. We hypothesize that MRS and brain volumetry can be useful predictors of cognitive deterioration in amnestic-MCI patients.
PATIENTS AND METHODS
The initial cohort was composed of 52 patients with amnestic MCI who were followed for a mean period of 3 years (standard deviation [SD]: 6.7 months). However, 4 subjects were discarded due to problems of movement or processing. Therefore, 48 patients (30 female and 18 male) with amnestic MCI were finally included in the study. All of them underwent a MRI brain volumetry assessment, MRS and clinical examination at baseline were included in a longitudinal study. No differences were seen in the male/female ratio proportion (Chi-Square, p=0.528), Sex has a significant effect on the volume of the white (F= 29.79; P= <0.001) and gray matter (F=28.14; P <0.001) (males have significant larger volumes in comparison with females). Age has a significant (negative) correlation with the total amount of gray matter. (r Pearson = -0.40, p = 0.005).
A C C E P T E D M A N U S C R I P T [17] . Informed consent was obtained from the participants before their inclusion in the study. The study protocol was approved by the ethical review board of the regional health authority.
Neuropsychological examination.
The patients include here were referred by general practitioners because of memory complaints which were corroborated by relatives or caregivers. The were first screened for memory impairment with the Memory Impairment Screen (MIS) [18] , a simple delayed recall test. At baseline, the patients underwent the following neuropsychological examination: the Mini-Mental test (Spanish version with a maximum possible score of 35 points) [19] , the Blessed Dementia Rating Scale, the clock drawing test, the Geriatric Depression Scale Additionally, a T1 axial, a T1 sagittal, a T2 and a fluid-attenuated inversion recovery sequences were also acquired with clinical purposes.
Magnetic Resonance Spectroscopy.
For the quantitative regional analysis, a sagittal and axial T1 and axial T2-weighted image was used to locate a voxel or volume of interest (2 x 
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The postprocessing of data was done with the LCModel software, version 6.2-0 [20] . Concentration values were not corrected for contributions by cerebrospinal fluid or for small reductions in the numeric values because of residual T1 and T2 relaxation effects.
We also obtained the ratios of the metabolites relative to Cr. Spectra were rejected and repeated in the following cases: line width >10 Hz, line shape asymmetrical after eddy current correction and the presence of artifacts. Data fits with % SD >20 from the Cramér-Rao inequality were eliminated.
Both areas we examined showed excellent reproducibility in two previous studies of test-retest reliability carried out with the same clinical scanner in AD patients [21, 22] . For the NAA/Cr ratios, the α (the interclass correlation coefficient) value was 0.93 and 0.95 in the posteromedial bilateral parietal lobe respectively, and 0.89 and 0.87 in the left medial occipital lobe.
Brain Volumetry.
The T1-3D images were used for the assessment of the brain volumes.
After the qualitative quality control of the acquired images, they were blinded and sent to a workstation for analysis and post-processing. Before performing the volumetric measurements, all images were improved using a combination of two spatial filters. First, a non-local filter [23] was applied to minimize the random fluctuation of the MR signal due to the thermal noise. This is especially relevant when semiautomatic quantitative measurements are being considered.
The resulting volumes showed a significant higher signal-to-noise ratio when compared with the original data. Then, images were also corrected for intensity heterogeneities which are usually present in MR images and depend on the sensitivity of the coils. A non-parametric method based on the minimization of an entropy-related function cost [24] was applied on each image to produce a non-biased corrected volume.
The Freesurfer software package (http://surfer.nmr.mgh.harvard.edu/) was used to perform the parcellation and the volumetric measurement of the 
Clinical follow-up
The patients were followed up and re-evaluated every 6 months or earlier to determine whether they had developed probable AD-type dementia according to the NINCDS-ADRDA group criteria [17] .
STATISTICS
All statistic tests were performed with the SPSS statistical package. Data derived from metabolite concentration and brain volumes were included in a statistical model alongside demographic and clinical variables. In order to minimize the risk of obtaining results related with macroscopic variability of the data (for example due to differences between males and females), all volumes were normalized by the total intracranial volume of each participant.
This volume was computed as the sum of the gray matter, white matter and the cerebrospinal fluid. As age was statistically different between groups of
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11 converters and non-converters (F=8.34; p=0.006), it was included as a covariate of interest in the model. Different tests were then performed to identify the automated measurements that best discriminated both groups of patients. For the ANOVA test, the assumptions of normality and homoscedasticity were tested. Homoscedasticity was tested by inspecting the Q-Q plots and by carrying out a Levene test. The Kolmogorov-Smirnov test was used to check the normality of the data. None of the considered variables in the study violated these assumptions.
In order to determine which variable (or combination of variables) was the best predictor of conversion to AD, we used a Fisher Linear Discriminant Analysis (LDA).
Three different LDA classifiers were tested, including a classifier with only variables from spectroscopy, a classifier with volumetric variables and a classifier with both, spectroscopic and volumetric measurements. All Fisher LDA classifiers were constructed and evaluated using a cross-validation strategy.
RESULTS
The ANCOVA model that included the brain volumetric measures after normalizing the values by the total intracranial volume showed that the most significant variable was the volume of the third ventricle (F= 4.382, p= 0.042).
With spectroscopy we found statistically significant variables for converters and non-converters: myo-inositol in occipital cortex (F= 6.332, p= 0.016); and the glutamate/creatine ratio (F=4.178, p=0.047) and glutamate + glutamine (Glx) in the ventral posterior cingulate cortex (F= 4.128, p= 0.049) ( Table 2 ). Volume measurements are given in table 3.
After the individual evaluation of each variable using an ANCOVA approach, a LDA analysis was applied to determine which combination of variables is the best predictor for converting to AD. Considering the brain volumetry assessment, the following variables represented the greatest percentages of correct prediction: 3rd ventricle, entorhinal cortex and total white matter. The classifier constructed with these three variables predicted (Fig. 2) .
A C C E P T E D M A N U S C R I P T
DISCUSSION
In our study, we have found that baseline third ventricle volume, Myoinositol in occipital cortex, the Glutamate/Creatine ratio, and Glutamate + Glutamine (Glx) levels in the posterior cingulate cortex in amnestic MCI predict with high risk of early conversion to AD in comparison with non-converters.
On the light of these results, it seems that MRS has more influence on the variable conversion to Alzheimer than volumetry (especially Myo-inositol in occipital cortex, the Glutamate/Creatine ratio (Glu/Cr), and Glutamate + Glutamine (Glx) levels in the posterior cingulate cortex). In the case of using a standardized total intracranial volume (TIV) and covariant age data, the only anatomical area showing a significant relationship with the variable conversion was the third ventricle volume.
With regard to MRS measurements, the myo-inositol in the occipital cortex + Glx in the posterior cingulate cortex, predicted with high specificity but
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13 low sensitivity the conversion of MCI to probable Alzheimer's disease. It is generally observed that the negative predictive value is quite high but the positive predictive value is low.
Several studies have shown the usefulness of 1H MRS in the early detection of AD [13, 15, [25] [26] [27] . 1H MRS has also detected biochemical abnormalities preceding brain atrophy and cognitive decline [28] . None of them included the levels of glutamate as predictor. In this study the accuracy of prediction of MRS was lower than in our two previous studies [13, 15] and comparable to volumetry, however the sample size is smaller and the follow-up period is shorter. The combination of MRS and volumetry was not superior to these techniques used individually.
Structural neuroimaging has also been validated as a tool to detect and monitor progression of AD. Tissue volumes in the central nervous system, and in particular changes in volume over time, are sensitive markers of disease progression. Manual segmentation to measure the hippocampal volume is recognized as the gold standard [29] . It has been found that atrophy of mesial temporal structures, such as the hippocampus and entorhinal cortex is predictive of progression to AD [30] . Using semi-automated segmentation threshold track, Jack et al. described a sensitivity of 82% and 80% specificity for discriminating AD patients in the control group in a study of 220 individuals [31] . Serial volumetric measurements in the prediction of AD and in evaluating the effectiveness of therapeutic regimens in high risk populations, particularly those with MCI, were also described. A study of 129 patients indicated that the hippocampal volume within 3 years follow-up revealed atrophy rates 10 times higher in patients with mild or moderate dementia compared with normal controls [4] . Another study found that rates of percentage reduction in brain volume, ventricles, hippocampus and temporal horn are more significant in patients with MCI who develop dementia compared to those who remained stable (32) . Structural MRI alone has also proven insufficient to predict early AD and additional biomarkers are needed in combination to make reliable predictions in MCI (33) . Myo-inositol reflects glial activation or
14 neuroinflammation associated with neuronal degeneration, and it is a sensitive marker reflecting pathological changes in MCI and AD [25, 34] . Kantarci et al [35] , studied subjects with microtubule-associated protein (MAPT) mutations. Their results indicated that the MI/Cr ratio, a possible index of glial activation, precedes the decrease of NAA/Cr, a neuronal integrity and hippocampal atrophy.
When analysing metabolite levels in the whole sample while controlling for age and gender, we observed that all metabolites were correlated with age.
N-acetylaspartate, glutamate and glutamate+glutamine and their ratios to creatine showed a negative correlation (increase in age with a decrease in metabolite levels and vice versa), while the remaining metabolites, such as myo-inositol and choline, show a direct correlation. A decrease in glutamate and glutamate+glutamine over time, which is associated with a certain cognitive deterioration, was found in Alzheimer´s Disease [36] . Decreased levels of N-acetylaspartate (NAA) or N-acetylaspartate/creatine ratios (NAA/Cr) are the most common finding reported in subjects with AD and MCI [37] [38] [39] , although alterations in other metabolites including myo-inositol [40] and glutamate [41] are also found. Glutamate levels have been studied on fewer occasions in MCI and AD. We previously demonstrated that glutamate levels are lower in AD and MCI than in healthy controls in the posterior cingulate gyrus [36, 42] .
Additional longitudinal studies showed valuable results with MRS. In a large cohort of 151 MCI patients (most of them being of amnestic type)
followed-up for 3 years, MRS was individually predictive of conversion to dementia but the accuracy of prediction improved when magnetic resonance spectroscopy was used in combination with hippocampal volumetry and the presence of cortical infarctions [43] . The value of proton magnetic resonance spectroscopy as a biomarker was assessed ante-mortem in a single study with 54 patients ranging from low to high likelihood of having AD and who underwent autopsy. Decreases in N-acetylaspartate/creatine and increases in myo-inositol/creatine ratios in the posterior bilateral cingulate gyrus correlated with higher postmortem Braak neurofibrillary tangle staging [16] .
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There are some caveats that influence metabolite measurements, such as magnetic field heterogeneity and cerebrospinal fluid (CSF), spatial resolution, signal-to-noise ratio, contrast-to-noise ratio contamination and artifacts. With the modern 3T scanners with smaller voxel analysed have overcome these limitations. Pitfalls in MRS can be minimised using automated and standard protocols. Given that the spectral patterns are well known, minor artifacts are relatively easy to identify.
With regard to other neuroradiological and biological predictors, SPECT has shown to be inferior to MRI techniques. According to the results of the largest ever cohort the overal accuracy was only 58% 44 . FDG-PET and amyloidbinding radiotracer PET are of superior value but both are costly and not widely available 38 . Protein tau and Beta42 amyloid peptide levels in the CSF are excellent predictors of conversion to AD 45 but they need lumbar puncture.
APOE genotype is also useful but only in terms of specificity 15, 38 . Therefore there is no clear consensus on what is the best biomarker of early AD.
In conclusion, both 1HMRS and brain volumetry are markers separately of cognitive decline and transition from MCI to AD. Given the high prevalence of AD and the predictive values below 80%, these techniques ar far from being useful as routine procedures in the clinical setting. 
